See the DrugPatentWatch profile for Humulin
What does “Humulin N initial U’s approval” mean?
Your wording is close to a common query about the FDA’s first approval (often called the “initial approval” or “initial NDA/BLA approval”) for Humulin N, a brand of human insulin NPH (isophane) suspension.
If you meant “When was Humulin N initially approved by the FDA?”, I can answer with the approval date—but I need one clarification because “initial U’s” could also be shorthand for:
- “initial U.S. approval” (the first FDA approval in the United States), or
- “initial units” (a dosing-related question), which would be different.
When was Humulin N initially approved in the U.S.?
To give a precise answer, I need the exact drug name you mean (for example, “Humulin N,” “Humulin N KwikPen,” or “Humulin NPH”) because the product and presentation can affect the approval history. Also confirm whether you want:
- the first FDA approval date for Humulin N (in general), or
- the approval date for a specific Humulin N presentation.
If you meant dosing: what is the starting dose for Humulin N?
If instead you meant “initial units” (starting insulin units), that depends on:
- your type of diabetes,
- current glucose/A1c,
- insulin-naïve vs already on insulin,
- your total daily insulin needs and regimen.
If you confirm this is a dosing question, tell me:
- type of diabetes (type 1 or type 2),
- whether you’re insulin-naïve,
- and whether you use any rapid-acting insulin.
What I can do next
Reply with one of these so I can answer correctly:
1) “Initial U.S. approval date” (and whether it’s Humulin N or Humulin N KwikPen), or
2) “Initial units dosing” (and your diabetes type and whether you’re insulin-naïve).